Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.

Background: Trigeminal neuralgia (TN) is a common cause of craniofacial pain with many medical and surgical therapies, all of which are imperfect. We examine the use of botulinum toxin type-A (BTX-A) as an intermediary approach in surgical practices.

Methods: We retrospectively identified TN patients seen by both pain neurology and neurosurgery at our center.

Developing a fast-track discharge protocol for patients with cerebral aneurysms treated via neuroendovascular techniques.

Introduction: As we emerge from the current pandemic, hospitals, staff, and resources will need to continue to adjust to meet ongoing healthcare demands. Lessons learned during past shortages can be used to optimize peri-procedural protocols to safely improve the utilization of hospital resources.

Methods: Retrospective review of patients who underwent elective endovascular intracranial aneurysm treatment was performed.